Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPeking University Third Hospital

About this trial

This study aims to evaluate the sensitivity and specificity of a multi-sensor wireless pressure microcatheter for the diagnosis of CMD in patients with ANOCA/INOCA, using quantitative myocardial perfusion imaging of cardiac magnetic resonance (CMR) as a reference.

Eligibility criteria

Qualifiers

Age ≥ 18 years, gender not limited;

Symptoms of angina pectoris, or objective evidence of myocardial ischemia (e.g., electrocardiogram, myocardial injury markers, etc.);

Visual assessment of coronary angiography shows diameter stenosis < 50% and FFR > 0.8 (or cRR > 0.89);

Microvascular function assessment is planned;

Disqualifiers

Acute myocardial infarction, PCI, CABG, or valvular surgery following angiography within the past 30 days;

Severe valvular disease requiring surgical or interventional treatment;

Chest pain with known non-ischemic causes (e.g., pericarditis, pulmonary hypertension, esophageal spasm);

Contraindications to CMR (e.g., certain types of pacemakers or defibrillators, severe claustrophobia);

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

3
Wang Jing Hospital Of CACMS(China Academy of Chinese Medical Sciences)100102, BeijingBeijing Municipality, China
Cangzhou Central Hospital CangzhouHebei, China
Chengdu Second People's Hospital ChengduSichuan, China

Sponsors and collaborators

Peking University Third Hospital

Lead sponsor